PortfoliosStock ScreensStocksStockXcel

Trevi Therapeutics Inc

TRVI | US

3.35

USD

0.23

7.37%

TRVI | US

About Trevi Therapeutics Inc

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

21/10/2024

Close

3.35

Open

3.16

High

3.44

Low

3.16

Trevi Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on the development and commercialization of Haduvio for the treatment of serious cough conditions targeting the central and peripheral nervous systems. The company is developing Haduvio an oral extended-release formulation of nalbuphine which is in phase 2b/3 clinical trial for the treatment of chronic pruritus chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven Connecticut.

View Less

TRVI | US

Risk
70.7
Sharpe
0.92
Luna's Score
54/100
Recommendation
Hold

Luna says (TRVI | US)

What's Working

Strength based on increasing price with high volume

High Current Volume and Positive 1-Day Return

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

What's not Working

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

71.7%

1 month

70.7%

3 months

68.4%

6 months

69.1%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

3.42

Debt to equity

0.02

Debt to assets

0.02

Ent. to EBITDA

-4.92

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-43.03M

MarketCap

243.18M

MarketCap(USD)

243.18M

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

-

Ret. on equity

-48.09

Short ratio

3.46

Short perc.

3.34

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

0.61

Range1M

0.73

Range3M

1.19

Volumes: Market Activity

Rel. volume

3.58

Price X volume

5.32M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
ChromaDex CorporationCDXCBiotechnology3.46262.73M-1.14%n/a10.17%
Rigel Pharmaceuticals IncRIGLBiotechnology14.81260.58M-1.99%n/a-201.68%
Mersana Therapeutics IncMRSNBiotechnology2.1257.62M0.00%n/a383.37%
2seventy bio IncTSVTBiotechnology4.97255.94M-0.40%n/a107.07%
Nektar TherapeuticsNKTRBiotechnology1.39255.87M-1.42%n/a275.58%
Compass Therapeutics Inc. Common StockCMPXBiotechnology1.85254.54M-0.54%n/a0.00%
Acrivon Therapeutics Inc.ACRVBiotechnology8.05249.33M-2.42%n/a1.95%
Poseida Therapeutics IncPSTXBiotechnology2.5242.83M2.04%n/a137.55%
MacroGenics IncMGNXBiotechnology3.86242.11M-3.74%n/a58.90%
Omeros CorporationOMERBiotechnology4.1237.58M-1.20%n/a-356.63%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
CPI Card Group IncPMTSBuilding Products & Equipment23.4261.09M-1.39%15.61-621.78%
Virco Mfg. CorporationVIRCBuilding Products & Equipment14.53236.68M-1.96%9.0939.79%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles7.55145.88M-0.79%n/a58.43%
Kewaunee Scientific CorporationKEQUBuilding Products & Equipment32.8794.40M1.83%5.1619.82%
Saga Communications IncSGABroadcasting - Radio14.2289.04M-1.80%14.487.10%
Urban One IncUONEKBroadcasting - Radio1.0153.54M-3.35%n/a268.43%
Beasley Broadcast Group IncBBGIBroadcasting - Radio13.4420.47M4.19%n/a204.46%
ILAGILAGBuilding Products & Equipment118.06M-2.91%n/a5.48%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment0.52637.69M-2.17%0.0316.03%
Twin Vee PowerCats Co. Common StockVEEERecreational Vehicles0.46594.44M-2.96%n/a19.98%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-4.92-Cheaper
Ent. to Revenue---
PE Ratio-41.03-
Price to Book3.4215.55Cheaper
Dividend Yield---
Std. Deviation (3M)68.37-Par
Debt to Equity0.02-1.23Expensive
Debt to Assets0.020.25Cheaper
Market Cap243.18M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007